| Nov 14 |
Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting
|
| Nov 8 |
Rapport Therapeutics expects cash to fund requirements through 2026
|
| Nov 7 |
Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update
|
| Nov 4 |
Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November
|
| Oct 18 |
This Rapport Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
|
| Sep 5 |
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences
|
| Aug 29 |
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit
|
| Aug 8 |
Rapport Therapeutics GAAP EPS of -$1.70 misses by $1.02
|
| Aug 8 |
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update
|
| Aug 6 |
3 Under-The-Radar Healthcare Stocks to Buy for Outsized Returns
|
